首页> 外文期刊>Nature >Licensing of natural killer cells by host major histocompatibility complex class I molecules
【24h】

Licensing of natural killer cells by host major histocompatibility complex class I molecules

机译:宿主主要组织相容性复杂的I类分子对自然杀伤细胞的许可

获取原文
获取原文并翻译 | 示例
       

摘要

Self versus non-self discrimination is a central theme in biology from plants(1) to vertebrates, and is particularly relevant for lymphocytes that express receptors capable of recognizing self-tissues and foreign invaders. Comprising the third largest lymphocyte population, natural killer (NK) cells recognize and kill cellular targets and produce pro-inflammatory cytokines. These potentially self-destructive effector functions can be controlled by inhibitory receptors for the polymorphic major histocompatibility complex (MHC) class I molecules that are ubiquitously expressed on target cells(2-4). However, inhibitory receptors are not uniformly expressed on NK cells, and are germline-encoded by a set of polymorphic genes that segregate independently from MHC genes(5,6). Therefore, how NK-cell self-tolerance arises in vivo is poorly understood. Here we demonstrate that NK cells acquire functional competence through 'licensing' by self-MHC molecules. Licensing involves a positive role for MHC-specific inhibitory receptors and requires the cytoplasmic inhibitory motif originally identified in effector responses. This process results in two types of self-tolerant NK cells - licensed or unlicensed - and may provide new insights for exploiting NK cells in immunotherapy. This self-tolerance mechanism may be more broadly applicable within the vertebrate immune system because related germline-encoded inhibitory receptors are widely expressed on other immune cells.
机译:从植物(1)到脊椎动物,自我与非自我歧视是生物学的中心主题,并且与表达能够识别自我组织和外来入侵者的受体的淋巴细胞特别相关。由第三大淋巴细胞组成的自然杀伤(NK)细胞识别并杀死细胞靶标并产生促炎性细胞因子。这些潜在的自我破坏效应器功能可以通过在靶细胞上普遍表达的多态性主要组织相容性复合物(MHC)I类分子的抑制性受体来控制(2-4)。然而,抑制性受体在NK细胞上的表达并不均匀,并且由与MHC基因独立分离的一组多态性基因进行种系编码(5,6)。因此,对NK细胞自我耐受如何在体内产生的了解很少。在这里,我们证明NK细胞通过自身MHC分子的“许可”获得功能能力。许可涉及MHC特异性抑制受体的积极作用,并且需要最初在效应子反应中鉴定的胞质抑制基序。该过程导致两种类型的自我耐受的NK细胞-许可的或未许可的-可能为在免疫疗法中利用NK细胞提供新的见解。由于在其他免疫细胞上广泛表达了相关种系编码的抑制性受体,因此这种自我耐受机制在脊椎动物免疫系统中可能更广泛地适用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号